M&A Deal Summary

Vetoquinol Acquires Bioniche s Animal Health Business - Bioniche Life Sciences

On February 28, 2014, Vetoquinol acquired healthcare services company Bioniche s Animal Health Business - Bioniche Life Sciences from Telesta Therapeutics for 61M CAD

Acquisition Highlights
  • This is Vetoquinol’s 5th transaction in the Healthcare Services sector.
  • This is Vetoquinol’s 0th largest (disclosed) transaction.
  • This is Vetoquinol’s 1st transaction in Canada.
  • This is Vetoquinol’s 1st transaction in Ontario.

M&A Deal Summary

Date 2014-02-28
Target Bioniche s Animal Health Business - Bioniche Life Sciences
Sector Healthcare Services
Buyer(s) Vetoquinol
Sellers(s) Telesta Therapeutics
Deal Type Divestiture
Deal Value 61M CAD

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vetoquinol

Lure, France

website


Category Company
Founded 1933
Sector Life Science
Employees2,525
Revenue 540M EUR (2022)
DESCRIPTION

Vetoquinol SA is a largest veterinary pharmaceutical company. Vetoquinol was founded in 1933 and is based in Lure, France.


DEAL STATS #
Overall 5 of 7
Sector (Healthcare Services) 5 of 5
Type (Divestiture) 1 of 2
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-25 Orsco Laboratoire Vétérinaire SAS

Neyron, France

Orsco Laboratoire Vétérinaire SAS develops and sells veterinary food supplements.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-03 Clarion Biociencias

Goiania, Brazil

Clarion Biociencias Ltda. is a veterinary laboratory based in the state of Goiás. Clarion Biociencias Ltda. employs around 180 people and has a state-of-the-art production facility.

Buy -

Seller(S) 1

SELLER

Telesta Therapeutics

Saint-Laurent, Quebec, Canada

website


Category Company
Founded 1979
Sector Life Science
Employees202
DESCRIPTION

Telesta Therapeutics, Inc. is a clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer.


DEAL STATS #
Overall 2 of 2
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 2 of 2
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-01 Bioniche Pharma Holdings

Lake Forest, Illinois, United States

Bioniche Pharma Holdings Ltd. is a developer and manufacturer of injectable pharmaceutical products serving a variety of niche markets, including analgesics/anesthetics, orthopedics, oncology, and urology.

Sell -